Drug Addiction and Overdose Prevention
Federal Government Announces $281 Million for Addiction and Mental Health Programs
| Reuters | Reuters | July 6, 2026
The Department of Health and Human Services announced more than $281 million in grants for addiction treatment, overdose prevention, mental health care, recovery services, workforce development, trauma programs, and specialized training for first responders.
FDA Broadens Access to Over-the-Counter Naloxone Nasal Spray
| U.S. Food and Drug Administration | FDA | July 2, 2026
The FDA expanded over-the-counter access to another naloxone nasal spray as part of an effort to make opioid-overdose reversal medication easier to obtain in pharmacies, stores, community programs, and other public locations.
Canada Reports Decline in Drug-Toxicity Deaths and Expands Federal Response
| Health Canada | Government of Canada | July 2026
Canadian officials reported a substantial decline in drug-toxicity deaths during 2025 while emphasizing that naloxone distribution, treatment, drug checking, surveillance, and community services remain necessary.
Rowan County Warns of Increase in Overdose Emergency Visits
| Rowan County Health Department | Rowan County Government | June 30, 2026
Rowan County health officials warned residents about increasing overdose-related emergency visits and a high rate of fentanyl-positive deaths while directing residents to naloxone, fentanyl test strips, treatment, and recovery services.
States Strengthen Partnerships to Prevent Drug Overdoses
| Clint Grant | Association of State and Territorial Health Officials | June 29, 2026
A multistate learning collaborative identified ways health departments can improve overdose prevention through partnerships, shared data, coordinated services, community engagement, and connections between public health and public safety agencies.
Federal Programs Ordered to Move Away from Some Overdose-Prevention Strategies
| Jessica Glenza | The Guardian | June 26, 2026
Federal health programs were directed to place less emphasis on certain harm-reduction approaches, raising concern among public-health specialists who believe naloxone, drug checking, and direct outreach contributed to falling overdose deaths.
Over-the-Counter Naloxone Expands Access but Gaps Remain
| Ryu Kariyawasam-Chavez and Alison Newman | Pharmacy Times | June 26, 2026
Over-the-counter naloxone has made the overdose-reversal medication more visible, but price, pharmacy participation, insurance limitations, stigma, and unequal distribution continue to restrict access in many communities.
European Drug Report Reviews Harm-Reduction Services
| European Union Drugs Agency | European Drug Report | June 9, 2026
European countries have expanded take-home naloxone, supervised drug-consumption services, infectious-disease prevention, syringe programs, drug checking, and other interventions intended to reduce overdose deaths and health complications.
National Drug-Control Strategy Emphasizes Prevention, Recovery and Public Safety
| Drug Free America Foundation | Drug Free America Foundation | May 27, 2026
The national strategy calls for prevention education, stronger recovery systems, expanded naloxone training, improved drug testing, treatment access, law enforcement coordination, and faster responses to emerging overdose clusters.
Mental-Health Conditions Frequently Appear in Overdose Death Investigations
| Centers for Disease Control and Prevention | CDC | May 27, 2026
CDC data show that many people who die from overdoses have evidence of a mental-health diagnosis or previous behavioral-health treatment, demonstrating the importance of integrating addiction and mental-health services.
U.S. Overdose Deaths Fell Again in 2025
| Associated Press | STAT | May 13, 2026
Preliminary federal data estimated approximately 70,000 overdose deaths in 2025, representing the third consecutive annual decline but still leaving the country with an extraordinarily high and preventable death toll.
Drug Overdose Deaths Declined for a Third Consecutive Year
| Mike Stobbe | Associated Press | May 13, 2026
The United States recorded another decrease in overdose deaths during 2025, although researchers cautioned that changes in government policy, treatment availability, naloxone access, or the illicit drug supply could reverse the improvement.
Social Conditions Help Identify Counties at Risk of Fentanyl Deaths
| Kabi Raj Tiruwa, Abhisan Ghimire and Anuj Kumar Shah | arXiv | May 6, 2026
Researchers found that disability, smoking, transportation limitations, health conditions, and inadequate treatment access could help identify counties vulnerable to fentanyl deaths before overdose mortality becomes more severe.
Federal Drug Strategy Promises Addiction Services Amid Funding Concerns
| KFF Health News | KFF Health News | May 6, 2026
The administration’s drug strategy endorses prevention, treatment, recovery, and naloxone while health-policy specialists question whether federal restructuring and funding reductions are compatible with those stated goals.
CDC Outlines Public-Health Strategies for Preventing Overdose
| Centers for Disease Control and Prevention | CDC | May 6, 2026
CDC guidance encourages communities to combine surveillance, prevention, evidence-based treatment, harm reduction, public-safety partnerships, community outreach, and programs addressing social conditions associated with overdose risk.
Kansas Permits Emergency Use of Expired Naloxone
| DCCCA | DCCCA | April 29, 2026
A Kansas law permits first responders and others to administer and distribute expired opioid antagonists when needed, helping prevent usable naloxone supplies from being discarded during an overdose emergency.
Federal Officials Restrict Funding for Test Strips and Syringe Services
| Lev Facher | STAT | April 27, 2026
New federal guidance limits the use of certain funds for fentanyl test strips and sterile syringes, marking a shift toward abstinence-focused policies and prompting objections from harm-reduction and addiction specialists.
Carfentanil Reemerges as an Extremely Potent Threat
| Associated Press | AP News | April 18, 2026
Carfentanil, a synthetic opioid far more powerful than fentanyl, has reappeared in the illicit drug supply and caused hundreds of deaths, creating new challenges for drug checking, overdose recognition, and naloxone response.
Advocates Urge Continued Federal Investment in Overdose Prevention
| Overdose Prevention Initiative | Advocacy Incubator | April 16, 2026
Written testimony urged Congress to sustain funding for community prevention, treatment, recovery support, overdose response, behavioral-health workers, first responders, drug courts, and public-health data systems.
Organizations Call for Sustained Overdose-Prevention Appropriations
| Overdose Prevention Initiative | Advocacy Incubator | April 13, 2026
Public-health organizations warned that reductions in federal overdose funding could undermine recent gains and called for continued support for prevention, treatment, harm reduction, recovery, surveillance, and community-based programs.
WHO Updates Guidance on Opioid Dependence and Overdose Prevention
| Pan American Health Organization | PAHO and WHO | April 6, 2026
Updated international recommendations support effective opioid-dependence treatment and community management of overdose, including wider access to opioid agonist medicines and overdose-reversal medications.
California Prisons Expand Access to Naloxone
| California Department of Corrections and Rehabilitation | Inside CDCR | March 24, 2026
California correctional facilities expanded naloxone availability for incarcerated people and staff as part of an effort to reduce fatal overdoses inside prisons and during the high-risk period following release.
Seventy-Two Thousand Annual Overdose Deaths Should Not Become Normal
| David A. Patterson Silver Wolf | STAT | March 9, 2026
Falling overdose numbers should not cause governments or the public to accept tens of thousands of preventable deaths as normal or withdraw funding before the crisis has been brought under control.
Powerful Opioid Antidote Failed to Replace Naloxone
| Lev Facher | STAT | January 29, 2026
The more powerful overdose-reversal spray Opvee struggled to gain acceptance because advocates questioned its cost, necessity, and increased potential to trigger severe opioid withdrawal compared with standard naloxone.
Overdose Deaths Continued Falling but at a Slower Rate
| Mike Stobbe | Associated Press | January 14, 2026
Provisional CDC figures showed overdose deaths declining through much of 2025, but the rate of improvement slowed and monthly deaths remained above levels recorded before the COVID-19 pandemic.
Federal Data Show Overdose Deaths Falling Through Most of 2025
| Associated Press | STAT | January 14, 2026
The longest sustained decline in overdose mortality in decades continued, but researchers warned that the progress remained fragile and unevenly distributed among states and communities.
Anonymous Text Alerts Warn Residents About Dangerous Drug Supplies
| Associated Press | AP News | January 9, 2026
An Indianapolis text-alert program anonymously warns people who use drugs about fentanyl, pressed pills, unusual overdoses, contaminated supplies, and the need to carry naloxone and test substances.
Lower Fentanyl Potency May Help Explain Declining Deaths
| Lev Facher | STAT | January 8, 2026
Researchers proposed that lower fentanyl potency, precursor-chemical restrictions, expanded naloxone, treatment access, and changes in drug-use patterns may all have contributed to declining overdose mortality.
Natural Disasters Disrupt Addiction Treatment
| KFF Health News | KFF Health News | January 2026
Hurricanes, floods, wildfires, and other emergencies can interrupt access to methadone, buprenorphine, pharmacies, transportation, counseling, and communication, placing people with substance-use disorders at greater risk of relapse and overdose.
The Future of Addiction Medicine Remains Contested
| KFF Health News | KFF Health News | January 7, 2026
Disagreements over abstinence, medications, harm reduction, professional standards, and political oversight illustrate the continuing struggle over how addiction medicine should treat and support people who use drugs.
Federal Cuts Could Undermine Alaska’s Response to Overdose Deaths
| The Guardian | The Guardian | December 15, 2025
Alaska faces geographic isolation, limited treatment capacity, high transportation costs, and increasing fentanyl deaths, while proposed federal cuts could weaken enforcement, Medicaid coverage, and community overdose programs.
Opioid Settlement Money Sometimes Pays for Questionable Expenses
| Aneri Pattani | KFF Health News | November 3, 2025
A national investigation found that some local governments used opioid-settlement money for law-enforcement equipment and routine expenses instead of concentrating the funds on addiction treatment, recovery, prevention, and overdose response.
Opioid Settlement Spending Database Reveals Local Priorities
| KFF Health News | KFF Health News | November 3, 2025
A searchable database provides thousands of examples showing how state and local governments are spending legal-settlement money intended to address the opioid crisis.
SAMHSA Updates Overdose Prevention and Response Toolkit
| Substance Abuse and Mental Health Services Administration | SAMHSA | July 28, 2025
The updated toolkit explains overdose risk factors, recognition, emergency response, naloxone and nalmefene, rescue breathing, calling emergency services, post-overdose care, and ways communities can establish prevention programs.
Artificial Intelligence Could Improve Overdose-Death Surveillance
| Arthur J. Funnell and colleagues | arXiv | July 16, 2025
Researchers demonstrated that clinical language models can identify drugs mentioned in medical-examiner records, potentially making overdose surveillance faster and improving detection of emerging substances.
Harm Reduction Becomes More Accepted at Music Festivals
| Liam McCollum | Associated Press | June 10, 2025
Music festivals are increasingly permitting nonprofit groups to distribute naloxone, provide overdose-response training, test drugs, and teach attendees how to reduce risks associated with contaminated substances.
Fentanyl Seizures Decline Along the United States-Mexico Border
| The Washington Post | The Washington Post | May 31, 2025
A major decline in border fentanyl seizures generated debate over whether the illicit supply was shrinking, traffickers had changed tactics, or precursor restrictions and cartel conflicts were altering production.
CDC Reports Largest One-Year Drop in Overdose Deaths
| National Center for Health Statistics | CDC | May 14, 2025
Provisional federal figures showed overdose deaths dropping sharply during 2024, providing evidence that prevention, treatment, naloxone, settlement investments, and changes in the drug supply may be saving lives.
United States Records 27 Percent Decline in Overdose Deaths
| Mike Stobbe | Associated Press | May 14, 2025
Approximately 30,000 fewer people died from overdoses in 2024 than in 2023, producing the largest single-year decline recorded in national overdose data.
Drug Overdose Deaths Drop to Lowest Level Since 2019
| Lev Facher | STAT | May 14, 2025
Fentanyl-related deaths declined substantially during 2024, although methamphetamine, cocaine, regional inequalities, and continued exposure to synthetic opioids remained important public-health concerns.
Administration’s Drug Strategy Mixes Enforcement and Treatment
| Lev Facher | STAT | April 3, 2025
An early federal drug-policy outline emphasized border enforcement and criminal penalties while also mentioning prevention, recovery, medications for addiction treatment, and naloxone.
Federal Health Reorganization Could Weaken Addiction Programs
| Amanda Seitz | Associated Press | March 28, 2025
Plans to absorb SAMHSA into a larger federal agency raised concern that addiction grants, crisis services, treatment programs, overdose prevention, and specialized expertise could lose visibility or funding.
Drug Overdoses Have Caused More Deaths Than the COVID-19 Pandemic
| Lev Facher | STAT | March 11, 2025
The cumulative overdose death toll illustrates the scale of the addiction crisis and the contrast between the emergency response to COVID-19 and the more fragmented response to drug-related deaths.
CDC Reports Nearly 24 Percent Decline in Overdose Deaths
| Centers for Disease Control and Prevention | CDC | February 25, 2025
Provisional data predicted approximately 87,000 overdose deaths during the 12 months ending in September 2024, down from roughly 114,000 during the preceding period.
Deleted Health-Equity Guidance Raised Overdose-Prevention Concerns
| Men’s Health | Men’s Health | 2025
Public-health specialists warned that removing federal information about housing, discrimination, trauma, employment, poverty, and other overdose risk factors could make evidence-based prevention more difficult.
World Drug Report Examines Global Drug Markets and Health Consequences
| United Nations Office on Drugs and Crime | United Nations | 2025
The World Drug Report reviews international drug production, trafficking, consumption, treatment access, overdose deaths, organized crime, emerging substances, and the health and social consequences of drug markets.
Research Uses Social-Media Language to Detect Opioid Risks
| Muhammad Ahmad and colleagues | arXiv | March 28, 2025
Researchers developed a system for recognizing opioid-related language in online discussions, with potential applications in surveillance, early warning, overdose detection, and understanding changing drug-use patterns.
Evidence-Based Drug Policy Is Essential During Political Change
| Samir Mitragotri and colleagues | National Library of Medicine | 2025
The authors argue that enforcement-focused approaches should not replace evidence-based prevention, treatment medications, naloxone, harm reduction, research, and policies addressing the health dimensions of addiction.
CDC Provides Evidence-Based Strategies to Prevent Youth Substance Use
| Centers for Disease Control and Prevention | CDC | August 15, 2025
The ENGAGE resource helps schools, families, health departments, and community organizations select interventions addressing youth risk factors, protective relationships, school environments, and early substance use.
Communities Need Continued Funding for Addiction and Overdose Programs
| Partnership to End Addiction | Partnership to End Addiction | 2025
Advocacy organizations warn that cuts to federal health agencies, Medicaid, prevention grants, and behavioral-health services could reduce treatment access and reverse recent declines in overdose mortality.
United States Overdose Deaths Begin a Rapid Reversal
| Mike Stobbe | Associated Press | November 13, 2024
National provisional data showed overdose mortality declining rapidly after years of increases, with researchers pointing to naloxone, treatment, outreach, reduced fentanyl exposure, and pandemic recovery as possible factors.
Health Departments Can Improve Overdose Surveillance
| Centers for Disease Control and Prevention | CDC | 2024
CDC overdose data help public-health agencies identify substances involved in deaths, detect geographic disparities, follow emerging trends, and direct prevention resources to communities experiencing the greatest risk.
Understanding Drug Overdose Death Rates
| National Institute on Drug Abuse | National Institutes of Health | 2024
National charts document changing overdose mortality involving synthetic opioids, heroin, prescription opioids, cocaine, methamphetamine, benzodiazepines, and combinations of multiple substances.
Naloxone Can Reverse an Opioid Overdose
| National Institute on Drug Abuse | National Institutes of Health | 2024
Naloxone rapidly blocks opioid effects and can restore breathing during an overdose, but emergency assistance is still necessary because its effects may wear off before the opioids leave the body.
Medications Effectively Treat Opioid-Use Disorder
| National Institute on Drug Abuse | National Institutes of Health | 2024
Methadone, buprenorphine, and naltrexone are evidence-based treatments that can reduce opioid use, withdrawal, criminal activity, infectious-disease risk, and mortality when combined with appropriate medical and social support.
Buprenorphine Expands Treatment Options for Opioid Addiction
| Substance Abuse and Mental Health Services Administration | SAMHSA | 2024
Buprenorphine reduces cravings and withdrawal and can be prescribed in medical settings, increasing the possibility that people will receive addiction treatment outside traditional opioid-treatment programs.
Methadone Remains a Highly Effective Addiction Treatment
| Substance Abuse and Mental Health Services Administration | SAMHSA | 2024
Methadone stabilizes opioid receptors, reduces withdrawal and cravings, and substantially lowers mortality when patients can obtain consistent treatment through appropriately regulated programs.
Naltrexone Blocks the Effects of Opioids
| Substance Abuse and Mental Health Services Administration | SAMHSA | 2024
Naltrexone is a non-opioid medication that blocks opioid effects and can support recovery, although patients must complete opioid withdrawal before beginning treatment.
Treatment Locators Help Families Find Addiction Services
| Substance Abuse and Mental Health Services Administration | FindTreatment.gov | 2024
The federal treatment locator allows users to search for substance-use and mental-health services by location, payment options, treatment type, medications offered, age group, and accessibility.
Higher-Dose Naloxone Did Not Produce Better Survival
| Mike Stobbe | Associated Press | February 8, 2024
A study found no survival advantage for an eight-milligram naloxone spray compared with the standard four-milligram dose, while the stronger product produced more withdrawal symptoms and vomiting.
Indiana’s Overdose Decline Shows the Value of Naloxone Investment
| Associated Press | AP News | June 2024
Indiana’s falling overdose deaths were linked to naloxone distribution, additional treatment capacity, settlement funding, recovery programs, and coordinated state and community action.
Preventing Opioid Overdose Requires Multiple Strategies
| Centers for Disease Control and Prevention | CDC | 2024
Effective overdose prevention combines safer prescribing, early intervention, treatment medications, naloxone, harm reduction, surveillance, recovery support, public education, and policies addressing social and economic risks.
Recognizing the Signs of an Opioid Overdose
| Centers for Disease Control and Prevention | CDC | 2024
Warning signs include unconsciousness, slowed or stopped breathing, choking or gurgling sounds, limpness, discolored lips, and pinpoint pupils, requiring immediate naloxone administration and emergency assistance.
Fentanyl Is Frequently Mixed into Other Drugs
| Centers for Disease Control and Prevention | CDC | 2024
Illicit fentanyl may be present in heroin, cocaine, methamphetamine, and counterfeit pills, making it difficult for users to know the potency or contents of a substance.
Fentanyl Test Strips Can Reduce Accidental Exposure
| Centers for Disease Control and Prevention | CDC | 2024
Drug-checking strips can detect fentanyl in many substances, allowing people to take precautions, avoid using alone, carry naloxone, use a smaller amount, or decide not to consume a tested drug.
Stigma Interferes with Addiction Treatment
| National Institute on Drug Abuse | National Institutes of Health | 2024
Stigmatizing language and discriminatory attitudes discourage people from seeking care, influence health professionals, encourage punitive policies, and obscure the fact that substance-use disorders are treatable medical conditions.
Words Matter When Discussing Addiction
| National Institute on Drug Abuse | National Institutes of Health | 2024
Person-first language such as “person with a substance-use disorder” reduces stigma and avoids defining an individual by a medical condition or behavior.
Overdose Risk Increases Following Release from Incarceration
| National Institute on Drug Abuse | National Institutes of Health | 2024
Reduced opioid tolerance, treatment interruption, unstable housing, and limited medical care make the period after jail or prison particularly dangerous, supporting treatment initiation before release and continuity afterward.
Polysubstance Use Complicates Overdose Response
| National Institute on Drug Abuse | National Institutes of Health | 2024
Combining opioids with alcohol, benzodiazepines, stimulants, or other substances can increase overdose risk, produce unpredictable symptoms, and complicate emergency treatment.
Xylazine Creates Additional Health Risks in the Drug Supply
| National Institute on Drug Abuse | National Institutes of Health | 2024
Xylazine is increasingly detected with fentanyl and can cause profound sedation, slowed breathing, severe wounds, and overdose complications that naloxone alone may not completely reverse.
Counterfeit Pills Frequently Contain Illicit Fentanyl
| Drug Enforcement Administration | DEA | 2024
Counterfeit medications sold outside licensed pharmacies may resemble legitimate painkillers or anxiety medicines while containing unpredictable and potentially lethal quantities of fentanyl.
Substance-Use Prevention Begins with Protective Environments
| Substance Abuse and Mental Health Services Administration | SAMHSA | 2024
Prevention programs can strengthen families, improve school climates, reduce trauma, delay initial substance use, increase social connection, and address community conditions that contribute to addiction.
Recovery Support Extends Beyond Medical Treatment
| Substance Abuse and Mental Health Services Administration | SAMHSA | 2024
Long-term recovery may require housing, employment assistance, peer services, education, transportation, family support, health care, community connection, and protection from discrimination.
Peer-Support Workers Strengthen Addiction Services
| Substance Abuse and Mental Health Services Administration | SAMHSA | 2024
People with lived recovery experience can help others navigate treatment, remain engaged in services, build trust, establish goals, and connect with housing, employment, and community resources.
Opioid Treatment Should Continue During Pregnancy
| American College of Obstetricians and Gynecologists | ACOG | 2024
Medical guidance generally recommends methadone or buprenorphine during pregnancy rather than abrupt withdrawal, which can increase the risk of relapse, overdose, and pregnancy complications.
Adolescents with Opioid Addiction Need Evidence-Based Treatment
| National Institute on Drug Abuse | National Institutes of Health | 2024
Young people benefit from early screening, confidential care, family involvement when appropriate, overdose education, naloxone, mental-health support, and access to effective addiction medications.
Primary-Care Clinics Can Treat Substance-Use Disorders
| Substance Abuse and Mental Health Services Administration | SAMHSA | 2024
Integrating addiction treatment into primary care reduces barriers, enables earlier diagnosis, coordinates mental and physical health services, and allows patients to receive treatment in familiar medical settings.
Emergency Departments Can Begin Buprenorphine Treatment
| National Institute on Drug Abuse | National Institutes of Health | 2024
Starting buprenorphine after an overdose or during opioid withdrawal can reduce cravings and create an immediate pathway from emergency care into continuing addiction treatment.
Overdose Survivors Need Rapid Follow-Up Care
| Centers for Disease Control and Prevention | CDC | 2024
A nonfatal overdose should trigger naloxone provision, assessment for substance-use disorder, medication initiation, mental-health screening, safety planning, and a direct connection to continuing treatment.
Pain Treatment and Overdose Prevention Must Be Balanced
| Centers for Disease Control and Prevention | CDC | 2024
Clinicians should use individualized pain treatment, discuss benefits and risks, monitor potentially dangerous medication combinations, avoid abrupt discontinuation, and offer treatment when opioid-use disorder is identified.
Prescription Drug Monitoring Programs Can Identify Risk
| Centers for Disease Control and Prevention | CDC | 2024
Monitoring databases can help clinicians identify overlapping prescriptions, dangerous medication combinations, multiple prescribers, and other patterns requiring careful review rather than automatic dismissal from care.
Safe Medication Storage Helps Prevent Accidental Poisoning
| U.S. Food and Drug Administration | FDA | 2024
Locking medications away from children and visitors and properly disposing of unused opioids can reduce accidental ingestion, diversion, misuse, and the circulation of leftover prescription drugs.
Drug Take-Back Programs Remove Unused Opioids from Homes
| Drug Enforcement Administration | DEA | 2024
Permanent collection locations and national take-back events allow households to dispose of unused controlled medications without placing them in household trash or leaving them accessible for misuse.
Family Members Can Learn to Administer Naloxone
| Substance Abuse and Mental Health Services Administration | SAMHSA | 2024
Families, friends, caregivers, service workers, and community members can be trained to recognize an opioid overdose, give naloxone, provide rescue breathing, and remain with the person until help arrives.
Good Samaritan Laws Encourage Emergency Calls
| National Conference of State Legislatures | NCSL | 2024
Many states provide limited legal protections for people who call emergency services during an overdose, although the scope of immunity and offenses covered varies among jurisdictions.
Naloxone Distribution Programs Place Medication in Communities
| California Department of Health Care Services | California Opioid Response | 2024
California supplies free naloxone to schools, libraries, community organizations, tribal groups, first responders, treatment providers, harm-reduction programs, shelters, and other eligible organizations.
New York Operates a Statewide Overdose-Prevention Network
| New York State Department of Health | New York State | 2024
Registered community programs provide free overdose-recognition training and naloxone kits while connecting participants with treatment, harm reduction, recovery, and health services.
Community Naloxone Cabinets Increase Public Access
| Remedy Alliance and Community Partners | Naloxone for All | 2024
Public naloxone boxes, vending machines, cabinets, and community distribution sites place overdose-reversal medication where it can be obtained anonymously and used immediately.
Syringe-Service Programs Connect People with Health Care
| Centers for Disease Control and Prevention | CDC | 2024
Syringe programs reduce infectious-disease transmission and can provide naloxone, testing, vaccinations, wound care, treatment referrals, sterile equipment, and trusted contact with health professionals.
Drug Checking Provides Information About the Illicit Supply
| National Institute of Standards and Technology | NIST | 2024
Laboratory and field-based drug analysis can identify fentanyl, xylazine, novel opioids, contaminants, and changing potency, supporting public warnings and more effective emergency responses.
Overdose Mapping Can Detect Sudden Clusters
| Washington-Baltimore High Intensity Drug Trafficking Area | ODMAP | 2024
Real-time overdose mapping helps public-health and public-safety agencies identify unusual increases, share alerts, distribute naloxone, investigate dangerous supplies, and coordinate community outreach.
Wastewater Surveillance May Reveal Drug Trends
| National Institute on Drug Abuse | National Institutes of Health | 2024
Wastewater testing and other surveillance methods may provide early information about changing patterns of drug consumption before hospital, arrest, or mortality data become available.
Housing Instability Increases Overdose Vulnerability
| Centers for Disease Control and Prevention | CDC | 2024
Homelessness, unstable housing, isolation, poverty, trauma, lack of transportation, and limited health care can increase overdose risk and interfere with consistent addiction treatment.
Rural Communities Face Distinct Treatment Barriers
| Rural Health Information Hub | RHIhub | 2024
Rural residents may face long travel distances, workforce shortages, limited methadone programs, inadequate broadband, stigma, emergency-response delays, and fewer recovery-support services.
Telehealth Can Expand Addiction Treatment
| U.S. Department of Health and Human Services | Telehealth.HHS.gov | 2024
Telehealth can connect patients with counseling, buprenorphine prescribers, behavioral-health specialists, peer workers, and follow-up care, particularly in rural or underserved areas.
Addiction Treatment in Jails Can Prevent Deaths
| Bureau of Justice Assistance | U.S. Department of Justice | 2024
Programs linking criminal-justice systems with treatment, overdose education, naloxone, reentry planning, peer navigation, and medications can reduce repeated incarceration and post-release mortality.
Overdose Diversion Can Connect People to Treatment Instead of Jail
| Veronica M. White and Laura A. Albert | arXiv | November 9, 2023
Modeling suggests that overdose diversion, arrest diversion, and reentry case management can reduce deaths and social costs when programs successfully connect eligible people with effective treatment.
Over-the-Counter Narcan Represents a Major Access Change
| U.S. Food and Drug Administration | FDA | March 29, 2023
FDA approval of the first nonprescription naloxone nasal spray allowed the medication to be sold directly in stores and online without requiring an individual prescription.
FDA Approves a Second Over-the-Counter Naloxone Product
| U.S. Food and Drug Administration | FDA | July 28, 2023
Approval of an additional nonprescription naloxone spray increased competition and created more opportunities for pharmacies, retailers, schools, workplaces, and community programs to stock overdose medication.
Overdose Education Should Include Rescue Breathing
| National Harm Reduction Coalition | National Harm Reduction Coalition | 2023
Effective response includes checking for breathing, calling emergency services, giving naloxone, providing rescue breaths when appropriate, administering another dose if necessary, and remaining with the person.
Never Use Alone Services Provide Remote Overdose Monitoring
| Never Use Alone | Never Use Alone | 2023
Remote monitoring services allow a person to contact a trained operator before using drugs so emergency responders can be called when the person becomes unresponsive.
Addiction Is a Treatable Chronic Medical Condition
| National Institute on Drug Abuse | National Institutes of Health | 2023
Repeated drug exposure can alter brain circuits involved in reward, judgment, stress, and self-control, but behavioral therapies, medications, social support, and sustained care can support recovery.
Relapse Does Not Mean Treatment Has Failed
| National Institute on Drug Abuse | National Institutes of Health | 2023
Because addiction is chronic and relapse can occur, treatment plans may need adjustment rather than abandonment, much as treatment is modified for other recurring medical conditions.
Treatment Retention Reduces Overdose Mortality
| National Institute on Drug Abuse | National Institutes of Health | 2023
Treatment is more effective when it is readily available, sustained long enough, tailored to individual needs, integrated with medical care, and supported by housing, employment, and family services.
Contingency Management Helps Treat Stimulant Addiction
| National Institute on Drug Abuse | National Institutes of Health | 2023
Contingency-management programs provide structured incentives for treatment attendance or drug-negative tests and have strong evidence for treating methamphetamine and cocaine-use disorders.
No FDA-Approved Medication Yet Exists for Stimulant-Use Disorder
| National Institute on Drug Abuse | National Institutes of Health | 2023
Methamphetamine addiction is generally treated with behavioral interventions and supportive care while researchers investigate medications and combinations that may reduce cravings and continued use.
Cocaine Overdose Deaths Often Involve Fentanyl
| National Institute on Drug Abuse | National Institutes of Health | 2023
Cocaine can cause heart attack, stroke, seizures, and overheating, while contamination or combined use with fentanyl has contributed to a major rise in fatal overdoses.
Benzodiazepines Increase the Danger of Opioid Use
| National Institute on Drug Abuse | National Institutes of Health | 2023
Opioids and benzodiazepines both suppress breathing, making their combined use especially dangerous and requiring careful prescribing, patient education, naloxone access, and monitoring.
Alcohol and Opioids Can Produce Fatal Respiratory Depression
| National Institute on Alcohol Abuse and Alcoholism | National Institutes of Health | 2023
Alcohol can intensify the sedating effects of opioids and other depressants, increasing the likelihood of unconsciousness, vomiting, breathing failure, brain injury, and death.
Public Schools Are Beginning to Stock Naloxone
| U.S. Department of Education and Federal Partners | SchoolSafety.gov | 2023
School naloxone policies can prepare nurses, teachers, coaches, and other staff to recognize overdoses, administer medication, contact emergency services, and respond to fentanyl exposure among students or visitors.
Libraries Have Become Overdose-Prevention Partners
Libraries increasingly provide naloxone, staff training, social workers, treatment information, peer outreach, and safe connections to community services because they frequently serve people experiencing homelessness or addiction.
Workplaces Can Prepare for Opioid Overdoses
| National Institute for Occupational Safety and Health | CDC | 2023
Employers can establish naloxone policies, train staff, reduce injury-related opioid risks, support confidential treatment, and provide recovery-friendly employment practices.
Recovery-Friendly Workplaces Reduce Stigma
| U.S. Department of Labor | Recovery-Ready Workplace Resource Hub | 2023
Recovery-ready workplaces use nondiscriminatory policies, employee assistance, treatment referrals, supervisor education, second-chance hiring, and supportive return-to-work practices.
Opioid Settlement Funds Should Supplement Existing Services
Public-health specialists recommend that settlement money be used to save lives, apply evidence, address racial and geographic inequalities, involve affected communities, and expand rather than replace existing funding.
Families Need Reliable Guidance After an Overdose
| Partnership to End Addiction | Partnership to End Addiction | 2023
Following a nonfatal overdose, families can obtain naloxone, discuss treatment without judgment, seek medical evaluation, remove immediate risks, establish an emergency plan, and connect the person with evidence-based care.
Motivational Interviewing Can Encourage Treatment Engagement
| Substance Abuse and Mental Health Services Administration | SAMHSA | 2023
Motivational interviewing uses empathy, collaboration, reflective listening, and exploration of personal goals to help individuals resolve uncertainty about changing substance use.
Trauma-Informed Care Improves Addiction Services
| Substance Abuse and Mental Health Services Administration | SAMHSA | 2023
Trauma-informed programs recognize the prevalence of adverse experiences, avoid retraumatization, create emotional and physical safety, and integrate trauma treatment with substance-use services.
Co-Occurring Mental Illness and Addiction Require Integrated Treatment
| Substance Abuse and Mental Health Services Administration | SAMHSA | 2023
Treating mental illness and substance-use disorder together improves coordination and reduces the risk that one untreated condition will undermine progress with the other.
Suicide Risk Should Be Assessed During Addiction Treatment
| Substance Abuse and Mental Health Services Administration | SAMHSA | 2023
Substance use can increase impulsivity, hopelessness, isolation, and access to lethal drugs, making suicide screening and crisis planning essential parts of addiction care.
Overdose Prevention Must Address Racial Disparities
| Centers for Disease Control and Prevention | CDC | 2023
Overdose mortality has risen disproportionately in some Black, American Indian, Alaska Native, rural, and economically marginalized communities, requiring culturally appropriate and locally led prevention strategies.
Tribal Communities Develop Culturally Grounded Recovery Programs
| Indian Health Service | IHS | 2023
Tribal responses combine medications, naloxone, traditional healing, family support, prevention education, behavioral-health care, and community-designed services addressing local needs.
Veterans Face Elevated Risks from Pain, Trauma and Substance Use
| U.S. Department of Veterans Affairs | VA Mental Health | 2023
Veterans may experience overlapping chronic pain, post-traumatic stress, depression, alcohol misuse, opioid exposure, and suicide risk, making coordinated mental-health and addiction treatment especially important.
Naloxone Should Be Available Wherever Overdoses May Occur
| U.S. Department of Health and Human Services | HHS | 2023
Federal overdose guidance encourages individuals, families, first responders, service organizations, and businesses to keep naloxone available and learn how to respond to a suspected opioid overdose.
Communities Can Build Comprehensive Recovery-Oriented Systems
| Substance Abuse and Mental Health Services Administration | SAMHSA | 2023
Recovery-oriented systems coordinate clinical treatment with peer services, housing, education, employment, family support, transportation, legal assistance, and long-term community participation.
Overdose Prevention Requires Maintaining Momentum
| Centers for Disease Control and Prevention | CDC | 2023
Declining deaths do not mean the overdose crisis has ended, and sustained progress depends on treatment access, naloxone, prevention, timely surveillance, public education, recovery support, and continued investment.
